We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Diagnostic and Monitoring Tool Helps Manage Asthma

By HospiMedica International staff writers
Posted on 28 Oct 2009
A new diagnostic tool measures a patient's wheezing before and after tests with a bronchodilator, thereby demonstrating the effectiveness of asthma treatments. More...


The KarmelSonix Wheezometer quantifies wheezing activity by measuring the wheeze rate (Wz%), the portion of the respiratory cycle occupied by wheezing. The device records thirty seconds of breathing while applied to the neck area and analyzes and quantifies the wheezing in the audio recording, obtaining spot check measurements of present wheeze activity as often as needed without any patient effort; the device allows scrolling of the last ten measurements for review. The device uses a cascade of six proprietary technologies to isolate and compare the signals against false detection of ambient noises as wheeze. The device comes with an embedded processor and a self-contained cushioned built-in silicone coated sensor with broad-spectrum frequency response, with more than a 60-decibel dynamic range and superior ambient noise rejection.

The technology is based on acoustic signal acquisition and processing, and advanced signal processing techniques. Acoustic markers such as wheezes, rhonchi, and cough are recorded using propriety lung-sound sensors specifically-designed for lung-sound detection and thus are more oriented in detecting sounds characteristic to asthma than normal stethoscopes. The acquired data is analyzed by patented algorithms and signal-processing techniques that map out the data's spectral content on a graphic sonogram. Outside noises are cancelled out using patented ambient noise rejection techniques, to ensure the accuracy of physiological sound detection. The device was calibrated and validated by consensus of a panel of experts who evaluated and scored many recordings for presence of wheeze.

The WheezoMeter design is based on ergonomic human interfacing principles as dictated by functional and anatomical requirements, and facilitates the correct anatomical placement of the device in contact with the trachea at the correct contact force. Stable contact with the skin surface is provided for the duration of the test. The device isolates the measuring head and sensor from vibrations and hand tremor, and an optional infant sensor holder is available to provide better skin contact for babies and toddlers. The WheezoMeter is a product of KarmelSonix (Alta Loma, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA) in addition to the European Community (CE) Marking.

Related Links:
KarmelSonix


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.